214 related articles for article (PubMed ID: 23970381)
1. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.
Pokala HR; Leonard D; Cox J; Metcalf P; McClay J; Siegel J; Winick N
Pediatr Blood Cancer; 2014 Feb; 61(2):276-80. PubMed ID: 23970381
[TBL] [Abstract][Full Text] [Related]
2. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
3. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
[TBL] [Abstract][Full Text] [Related]
4. Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).
Caira M; Candoni A; Verga L; Busca A; Delia M; Nosari A; Caramatti C; Castagnola C; Cattaneo C; Fanci R; Chierichini A; Melillo L; Mitra ME; Picardi M; Potenza L; Salutari P; Vianelli N; Facchini L; Cesarini M; De Paolis MR; Di Blasi R; Farina F; Venditti A; Ferrari A; Garzia M; Gasbarrino C; Invernizzi R; Lessi F; Manna A; Martino B; Nadali G; Offidani M; Paris L; Pavone V; Rossi G; Spadea A; Specchia G; Trecarichi EM; Vacca A; Cesaro S; Perriello V; Aversa F; Tumbarello M; Pagano L;
Haematologica; 2015 Feb; 100(2):284-92. PubMed ID: 25638805
[TBL] [Abstract][Full Text] [Related]
5. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study.
Even C; Bastuji-Garin S; Hicheri Y; Pautas C; Botterel F; Maury S; Cabanne L; Bretagne S; Cordonnier C
Haematologica; 2011 Feb; 96(2):337-41. PubMed ID: 21071502
[TBL] [Abstract][Full Text] [Related]
6. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
[TBL] [Abstract][Full Text] [Related]
7. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
[TBL] [Abstract][Full Text] [Related]
8. Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy.
Tüfekçi Ö; Yılmaz Bengoa Ş; Demir Yenigürbüz F; Şimşek E; Karapınar TH; İrken G; Ören H
Turk J Haematol; 2015 Dec; 32(4):329-37. PubMed ID: 25913290
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
[TBL] [Abstract][Full Text] [Related]
10. High Infection-Related Mortality in Pediatric Acute Myeloid Leukemia without Preventive Antibiotics and Antifungals: Retrospective Cohort Study of a Single Center from a Middle-Income Country.
Zengin E; Sarper N; Aylan Gelen S; Demirsoy U; Karadoğan M; Çakı Kılıç S; Öncel S; Arısoy ES; Dündar D
Turk J Haematol; 2017 Dec; 34(4):340-344. PubMed ID: 28351828
[TBL] [Abstract][Full Text] [Related]
11. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
12. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
[TBL] [Abstract][Full Text] [Related]
13. Infections in acute lymphoblastic leukaemia.
Chong CY; Tan AM; Lou J
Ann Acad Med Singap; 1998 Jul; 27(4):491-5. PubMed ID: 9791652
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal diseases in patients with acute lymphoid leukemia.
Nicolato A; Nouér SA; Garnica M; Portugal R; Maiolino A; Nucci M
Leuk Lymphoma; 2016 Sep; 57(9):2084-9. PubMed ID: 26949001
[TBL] [Abstract][Full Text] [Related]
15. [Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].
Selvy N; Villiet M; Hansel-Esteller S
Pathol Biol (Paris); 2010 Apr; 58(2):123-6. PubMed ID: 19864087
[TBL] [Abstract][Full Text] [Related]
16. Invasive Fungal Infections in Children With Acute Myeloid Leukemia: A Single-center Experience Over 19 Years.
Avcu G; Karadas N; Goktepe SO; Bal ZS; Metin DY; Polat SH; Aydinok Y; Karapinar DY
J Pediatr Hematol Oncol; 2023 Oct; 45(7):392-397. PubMed ID: 37526370
[TBL] [Abstract][Full Text] [Related]
17. Risks and outcome of fungal infection in neutropenic children with hematologic diseases.
Aytaç S; Yildirim I; Ceyhan M; Cetin M; Tuncer M; Kara A; Cengiz AB; Seçmeer G; Yetgin S
Turk J Pediatr; 2010; 52(2):121-5. PubMed ID: 20560245
[TBL] [Abstract][Full Text] [Related]
18. Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy.
Gözdaşoĝlu S; Ertem M; Büyükkeçeci Z; Yavuzdemir S; Bengisun S; Ozenci H; Taçyildiz N; Unal E; Yavuz G; Deda G; Aysev D
Med Pediatr Oncol; 1999 May; 32(5):344-8. PubMed ID: 10219335
[TBL] [Abstract][Full Text] [Related]
19. Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia.
Fisher BT; Kavcic M; Li Y; Seif AE; Bagatell R; Huang YS; Zaoutis T; Torp K; Leckerman KH; Aplenc R
Clin Infect Dis; 2014 Feb; 58(4):502-8. PubMed ID: 24270167
[TBL] [Abstract][Full Text] [Related]
20. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]